Cited by 101Thyroid Disorders and TreatmentsAcute Myocardial Infarction ResearchHormonal and reproductive studies

Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction

Friberg, Leif, Drvota, Viktor, Bjelak, Aida Hot, Eggertsen, Gösta, Ahnve, Staffan·2001·The American Journal of Medicine

Abstract

Purpose The thyroid hormone system may be downregulated temporarily in patients who are severely ill. This "euthyroid sick syndrome" may be an adaptive response to conserve energy. However, thyroid hormone also has beneficial effects on the cardiovascular system, such as improving cardiac function, reducing systemic vascular resistance, and lowering serum cholesterol levels. We investigated whether thyroid hormone levels obtained at the time of myocardial infarction are associated with subsequent mortality.Patients and methods Serum levels of thyroid hormones (triiodothyronine [T3], reverse T3, free thyroxine [T4], and thyroid-stimulating hormone) were measured in 331 consecutive patients with acute myocardial infarction (mean age [+/- SD], 68 +/- 12 years), from samples obtained at the time of admission.Results Fifty-three patients (16%) died within 1 year. Ten percent (16 of 165) of patients with reverse T3 levels (an inactive metabolite) >0.41 nmol/L (the median value) died within the first week after myocardial infarction, compared with none of the 166 patients with lower levels (P <0.0004). After 1 year, the corresponding figures were 24% (40 of 165) versus 7.8% (13 of 166; P <0.0001). Reverse T3 levels >0.41 nmol/L were associated with an increased risk of 1-year mortality (hazard ratio = 3.0; 95% confidence interval: 1.4 to 6.3; P = 0.005), independent of age, previous myocardial infarction, prior angina, heart failure, serum creatinine level, and peak serum creatine kinase-MB fraction levels.Conclusion Determination of reverse T3 levels may be a valuable and simple aid to improve identification of patients with myocardial infarction who are at high risk of subsequent mortality.

Integrity signals

Registry

Crossref · 10.1016/s0002-9343(01)00980-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An increase in reverse triiodothyronine is a predictor of both short- and long-term mortality independent of other traditional parameters.

    “The increase in rT 3 , the inactive TH metabolite, is a predictor of both short-and long-term mortality independent of other traditional parameters (120).”

    From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [120]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Friberg, L., Drvota, V., Bjelak, A. H., Eggertsen, G., & Ahnve, S.
Affiliations
Karolinska Institutet (SE)
Corresponding author
Ahnve, Staffan
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2001-12
Volume
111
Issue
9
Pages
699-703
ISSN
0002-9343 (ISSN-L)
OpenAlex
W2046316442
Cited by
101
References
25
Citations by year
2025: 3 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 12 · 2019: 4 · 2018: 8 · 2017: 2 · 2016: 8 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 5
FWCI
1.15
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Karolinska Institutet
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
reverse T3, acute myocardial infarction, mortality, low T3 syndrome, thyroid hormones, triiodothyronine, free thyroxine, thyroid-stimulating hormone, cardiovascular risk stratification, prognostic factors
MeSH terms
Aged, Female, Humans, Male, Myocardial Infarction, Prognosis, Sweden, Triiodothyronine, Reverse, Biomarkers, Multivariate Analysis, Proportional Hazards Models, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review